NEW STABILITY-INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ROSUVASTATIN (CALCIUM) IN PHARMACEUTICAL DOSAGE FORMS

Abstract

A stability indicating, accurate, specific, linear and sensitive reverse phase-HPLC method was developed and validated for the determination of Rosuvastatin calcium (ROS) in pharmaceutical dosage form. The chromatographic separation was performed using Eclipse XDB plus C18 Column (4.6 × 150 mm, 5μm particle size). Mobile phase was made by using Acetonitrile: Water (60:40 v/v) at a flow rate of 1.0 ml/min with the detection wavelength at 242 nm. The retention time of ROS was found to be about 1.787 min. The linearity was obtained in the concentration range of 10-50 μg/ml with a correlation coefficient of 0.999. The percentage purity of ROS was found to be 100.06 %. The percentage recovery was determined for ROS and found to be 100.53 %. The developed analytical method was validated for linearity, precision, accuracy, ruggedness, robustness, specificity and system suitability which were within the acceptance limit according to ICH guidelines. All the degradation products obtained by stress conditions were found to be well separated from the principal peak, which means that the ROS peaks were highly pure in all chromatograms obtained. The developed method was found to be applicable for routine quality control and stability analysis of ROS in pharmaceutical dosage forms.

Authors and Affiliations

Usha Rani N, Nagoor Ankani

Keywords

Related Articles

PHARMACOGNOSTIC, PHYTOCHEMICAL ANALYSIS AND ANTI DIABETIC ACTIVITY OF DRIED LEAVES OF ABRUS PRECATORIUS – AN IN VIVO APPROACH

Diabetes mellitus is among the most common disorder in developed and developing countries, and the disease is increasing rapidly in most parts of the world. It has been estimated that up to one-third of patients with dia...

Development and Correlation between in vitro Drug Release and in vitro Permeation of Thermally Triggered Mucoadhesive in situ Nasal Gel of Repaglinide PVP K30 Complex

The aim of the investigation was to develop and evaluate thermoreversible in situ nasal gel formulations of repaglinide (REP) and to establish correlation between its in vitro release and ex vivo permeation profiles. The...

EXTENDED RELEASE MICRO-PELLETS OF CHIRAL MOLECULE OF METOPROLOL SUCCINATE BY FLUID BED TECHNOLOGY

The objective is to prepare extended release micro-pellets of the s-Metoprolol Succinate which is chirally pure molecules. Commercially Metoprolol Succinate is available the racemic mixture of the s and r isomers. Out of...

LC AND LC-MS STUDY ON STRESS DECOMPOSITION BEHAVIOR OF PACLITAXEL AND ESTABLISHMENT OF VALIDATED STABILITY-INDICATING ASSAY METHOD

Paclitaxel was subjected to different ICH prescribed stress conditions of thermal stress, hydrolysis, oxidation and photolysis. In total, six major degradation products were detected by LC and to elucidate the degradatio...

DESIGN AND IN VIVO EVALUATION OF CONTROLLED RELEASE GLICLAZIDE TRILAYER MATRIX TABLETS IN THE MANAGEMENT OF DIABETES MELLITUS

The purpose of the present study was to develop and optimize multi-layered matrix tablets of Gliclazide trilayer tablets to achieve zero-order drug release for sustained plasma concentration. Gliclazide tablets were prep...

Download PDF file
  • EP ID EP624999
  • DOI -
  • Views 46
  • Downloads 0

How To Cite

Usha Rani N, Nagoor Ankani (2014). NEW STABILITY-INDICATING RP-HPLC METHOD DEVELOPMENT AND VALIDATION FOR THE DETERMINATION OF ROSUVASTATIN (CALCIUM) IN PHARMACEUTICAL DOSAGE FORMS. International Journal of Pharmaceutical Sciences and Drug Research, 6(4), 283-290. https://europub.co.uk/articles/-A-624999